SuperworthXenon Pharmaceuticals shares outstanding XENE
Diluted shares outstanding, averaged over each quarter, from 2013.
- Latest quarter, to Jun 30, 2026
- 99.6M
- On a year earlier
- +26.2%
- more shares
Xenon Pharmaceuticals had 99.6M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 26.2% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 80.1M | +2% |
| FY2024 | 78.4M | +12% |
| FY2023 | 69.9M | +7% |
| FY2022 | 65.6M | +23% |
| FY2021 | 53.2M | +52% |
| FY2020 | 35M | +32% |
| FY2019 | 26.4M | +5% |
| FY2018 | 25.2M | +40% |
| FY2017 | 18M | +1% |
| FY2016 | 17.9M | +24% |
| FY2015 | 14.4M | +52% |
| FY2014 | 9.5M | +257% |
| FY2013 | 2.7M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 99.6M | +26% | |
| Q1 FY26 | 87.3M | +11% | |
| Q4 FY25 | 80.1M | +2% | |
| Q3 FY25 | 79.2M | +2% | |
| Q2 FY25 | 79M | +2% | |
| Q1 FY25 | 78.7M | +1% | |
| Q4 FY24 | 78.4M | +12% | |
| Q3 FY24 | 77.9M | +18% | |
| Q2 FY24 | 77.7M | +18% | |
| Q1 FY24 | 77.6M | +18% | |
| Q4 FY23 | 69.9M | +7% | |
| Q3 FY23 | 66M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Xenon Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.